These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4099912)

  • 1. Thrombocytopenia and L.E. cells after oxyphenbutazone.
    Handley AJ
    Lancet; 1971 Jan; 1(7692):245-6. PubMed ID: 4099912
    [No Abstract]   [Full Text] [Related]  

  • 2. Amegakaryocytic thrombocytopenia and an analgesic.
    Font J; Nomdedeu B; Martinez-Orozco F; Ingelmo M; Balcells A
    Ann Intern Med; 1981 Dec; 95(6):783. PubMed ID: 7305167
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxyphenbutazone (Tanderil) and blood dyscrasia.
    Brownlie BE; Strang PJ
    N Z Med J; 1969 Feb; 69(441):77-9. PubMed ID: 5252205
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I.
    Chaplin S
    Adverse Drug React Acute Poisoning Rev; 1986; 5(2):97-136. PubMed ID: 3529881
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced blood dyscrasias in Sweden.
    Böttiger LE; Westerholm B
    Br Med J; 1973 Aug; 3(5875):339-43. PubMed ID: 4723818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxyphenbutazone-induced goitre.
    Lane RJ; Clark F; McCollum JK
    Postgrad Med J; 1977 Feb; 53(616):93-5. PubMed ID: 141661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
    Inman WH
    Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions with long-term use of phenylbutazone and oxyphenbutazone.
    Sperling IL
    Lancet; 1969 Sep; 2(7619):535-7. PubMed ID: 4184850
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxyphenbutazone-induced parotitis.
    Gross L
    Ann Intern Med; 1969 Jun; 70(6):1229-30. PubMed ID: 5789512
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pancreas irritation caused by oxyphenbutazone (Tanderil)].
    van Dijk E
    Ned Tijdschr Geneeskd; 1984 Jan; 128(1):45. PubMed ID: 6694768
    [No Abstract]   [Full Text] [Related]  

  • 11. Ulcer of the cecum during oxyphenbutazone (tandearil) therapy.
    Debenham GP
    Can Med Assoc J; 1966 May; 94(22):1182-4. PubMed ID: 5934387
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: diffuse pulmonary disorder caused by oxyphenbutazone.
    Cameron DC
    Br Med J; 1975 May; 2(5969):500-1. PubMed ID: 1148675
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oxyphenbutazone and leukemia--statistical aspects].
    Råde L
    Lakartidningen; 1966 Feb; 63(8):733-6. PubMed ID: 5917148
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pancreas irritation caused by oxyphenbutazone (Tanderil)].
    Versteegh MI; Vijverberg PL; van Dijk HA
    Ned Tijdschr Geneeskd; 1983 Oct; 127(42):1924-5. PubMed ID: 6196647
    [No Abstract]   [Full Text] [Related]  

  • 15. Withdrawal of oxyphenbutazone: what about phenylbutazone?
    Biron P
    CMAJ; 1986 May; 134(10):1119-20. PubMed ID: 3697857
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenylbutazone, oxyphenbutazone and aplastic anaemia.
    Böttiger LE
    Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pulmonary adverse effects of oxyphenbutazone].
    Lakartidningen; 1977 May; 74(21):2109. PubMed ID: 865186
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenylbutazone and oxyphenbutazone: time to call a halt.
    Drug Ther Bull; 1984 Jan; 22(2):5-6. PubMed ID: 6692755
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of typhoid and paratyphoid fever with the furazolidone-oxyphenbutazone combination].
    Borel H; Gonzalez O; Hazbun M; Perroni J
    Rev Med Chil; 1971 Jun; 99(6):416-8. PubMed ID: 4997971
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenylbutazone, oxyphenbutazone labeling revised.
    FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.